Literature DB >> 9443840

Dose-dependent brainstem neuropathology following repeated arteether administration in rats.

R F Genovese1, D B Newman, Q Li, J O Peggins, T G Brewer.   

Abstract

Histopathological effects of the artemisinin antimalarial, beta-arteether, were evaluated in rats. Arteether (3.125-12.5 mg/kg/day, IM, in sesame oil) was administered for 7 consecutive days. Seven days following the last injection, histological evaluation of the brainstem was performed. Rats treated with 12.5 mg/kg showed significant neuropathology, including chromatolysis, in the nucleus trapezoideus and nucleus superior olive. To a lesser extent, neuropathology was present in the nucleus ruber. Mild neuropathology was also detected in other brainstem regions examined. Although no statistically significant neuropathology was found for the groups treated with 6.25 mg/kg/day and 3.125 mg/kg/day, substantial neuropathology was observed in a single rat in each of these treatment conditions. These results confirm and extend previous studies demonstrating brainstem neurotoxicity from artemisinin antimalarials. Furthermore, these results suggest that, in rats, brainstem auditory pathways may be particularly vulnerable. Early detection of arteether neuropathology may, therefore, require examination of auditory functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443840     DOI: 10.1016/s0361-9230(97)00339-0

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  12 in total

1.  Establishment of an in vitro screening model for neurodegeneration induced by antimalarial drugs of the artemisinin-type..

Authors:  G Schmuck; R K Haynes
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  Effects of artemisinin in broiler chickens following chronic oral intake.

Authors:  Amir Ali Shahbazfar; Seyed Hossein Mardjanmehr; Hossein Ali Arab; Ali Rassouli; Mohammad Abdollahi
Journal:  Trop Anim Health Prod       Date:  2011-01-01       Impact factor: 1.559

3.  Neurotoxic mode of action of artemisinin.

Authors:  Gabriele Schmuck; Elke Roehrdanz; Richard K Haynes; Regine Kahl
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

4.  Recent Advances in the Prophylaxis and Treatment of Malaria.

Authors:  Annie-Claude Labbé; Mona R. Loutfy; Kevin C. Kain
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

5.  Arteether toxicokinetics and pharmacokinetics in rats after 25 mg/kg/day single and multiple doses.

Authors:  Q G Li; R P Brueckner; J O Peggins; K M Trotman; T G Brewer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jul-Sep       Impact factor: 2.569

6.  Intravenous artesunate for severe malaria in travelers, Europe.

Authors:  Thomas Zoller; Thomas Junghanss; Annette Kapaun; Ida Gjorup; Joachim Richter; Mats Hugo-Persson; Kristine Mørch; Behruz Foroutan; Norbert Suttorp; Salih Yürek; Holger Flick
Journal:  Emerg Infect Dis       Date:  2011-05       Impact factor: 6.883

7.  Reversible audiometric threshold changes in children with uncomplicated malaria.

Authors:  George O Adjei; Bamenla Q Goka; Emmanuel Kitcher; Onike P Rodrigues; Ebenezer Badoe; Jorgen A L Kurtzhals
Journal:  J Trop Med       Date:  2013-03-07

8.  Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand.

Authors:  Verena I Carrara; Aung P Phyo; Paw Nwee; Ma Soe; Hsar Htoo; Jaruwan Arunkamomkiri; Pratap Singhasivanon; François Nosten
Journal:  Malar J       Date:  2008-11-06       Impact factor: 2.979

9.  Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.

Authors:  George O Adjei; Jorgen A L Kurtzhals; Onike P Rodrigues; Michael Alifrangis; Lotte C G Hoegberg; Emmanuel D Kitcher; Ebenezer V Badoe; Roberta Lamptey; Bamenla Q Goka
Journal:  Malar J       Date:  2008-07-11       Impact factor: 2.979

10.  Adverse drug events resulting from use of drugs with sulphonamide-containing anti-malarials and artemisinin-based ingredients: findings on incidence and household costs from three districts with routine demographic surveillance systems in rural Tanzania.

Authors:  Joseph D Njau; Abdulnoor M Kabanywanyi; Catherine A Goodman; John R Macarthur; Bryan K Kapella; John E Gimnig; Elizeus Kahigwa; Peter B Bloland; Salim M Abdulla; S Patrick Kachur
Journal:  Malar J       Date:  2013-07-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.